Skip to content

Clinical trials

Terminated Colorectal Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Status: Terminated Country / region: Australia Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20133
20142
20151
20162
20171
20182
20194
20203
20214
20224
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Bristol-Myers Squibb2
Eli Lilly and Company2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
3B Pharmaceuticals GmbH1
AbbVie1
Actym Therapeutics, Inc.1
Amgen1
Aminex Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms35
Carcinoma, Non-Small-Cell Lung12
Neoplasm Metastasis7
Neoplasms6
Breast Neoplasms5
Head and Neck Neoplasms5
Melanoma5
Pancreatic Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Stomach Neoplasms5

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.